TCR2 THERAPEUTICS INC. Quarterly Operating Lease, Liability in USD from Q4 2020 to Q1 2023

Taxonomy & unit: us-gaap: GBP and USD
Description: Present value of lessee's discounted obligation for lease payments from operating lease.
Summary: Tcr2 Therapeutics Inc. quarterly Operating Lease, Liability history and growth rate from Q4 2020 to Q1 2023.
Tcr2 Therapeutics Inc. Operating Lease, Liability for the quarter ending March 31, 2023 was $5.98M, a 88.9% decline year-over-year.

Operating Lease, Liability, Quarterly (USD)

Operating Lease, Liability, YoY Quarterly Growth (%)

Period	Value	YoY Chg	Change %	Date	Report	Filed
Q1 2023	$5.98M	-$47.7M	-88.9%	Mar 31, 2023	10-Q	2023-05-11
Q4 2022	$25.2M	-$1.21M	-4.6%	Dec 31, 2022	10-K	2023-03-23
Q3 2022	$58.2M	+$31.1M	+115%	Sep 30, 2022	10-Q	2022-11-08
Q2 2022	$63.8M	+$36.1M	+131%	Jun 30, 2022	10-Q	2022-08-08
Q1 2022	$53.7M			Mar 31, 2022	10-Q	2022-05-12
Q4 2021	$26.4M	+$14.6M	+123%	Dec 31, 2021	10-Q	2022-11-08
Q3 2021	$27.1M			Sep 30, 2021	10-Q	2021-11-10
Q2 2021	$27.6M			Jun 30, 2021	10-Q	2021-08-05
Q4 2020	$11.8M			Jan 1, 2021	10-K	2022-03-22

* An asterisk sign (*) next to the value indicates that the value is likely invalid.